Donna Digiovanni
|Subscribers
About
Stay on top of latest health news from Harvard Medical School. Sign up for HEALTHBeat and receive trusted health information delivered right to your inbox. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician. As a service to our readers, Harvard Health Publishing provides access to our library of archived content. If your doctor can identify the source for declining levels—for instance, weight gain or a particular medication—he or she may first address that problem. Prostate cancer is another concern, as testosterone can fuel its growth.
A more personalized, proactive partnership should protect against over-treatment just as much as under-treatment. That is why good hormone care depends on more than a screenshot of a lab result. In transdermal therapy, timing matters differently. One reason lab conversations around TRT become confusing is that testosterone values are not independent of timing. In younger men, some authors have argued that a one-size-fits-all cutoff may miss clinically relevant low values when symptoms are present.
It is to stay within the physiologic range for women while assessing whether the symptom that justified therapy is actually improving. The question of women's TRT target levels is even more delicate. In healthy nonobese men aged 19 to 39, harmonized reference work identified an approximate normal range of 264 to 916 ng/dL, with a median near 531 ng/dL. These steps help ensure that TRT management remains aligned with medical safety and military readiness standards while protecting career progression and mission capability. Service members considering or currently on TRT should take deliberate steps to align treatment with military requirements. A medical waiver process allows service members to continue in service if the treating clinician and military medical evaluators agree that the therapy won’t impair readiness or safety. Regular blood work is typically mandated to monitor testosterone levels, hematocrit, lipid profile, liver enzymes, and prostate-specific markers when appropriate.
The overall objective is to determine whether TRT can be safely maintained without compromising mission readiness or the health of the service member. The process emphasizes transparent communication between the service member, medical providers, and the unit leadership. In some cases, a service member on TRT may be temporarily or permanently deemed non-deployable, depending on the stability of the condition and the stability of the treatment plan. Commanders and medical boards may consider whether the therapy affects physical readiness, cognitive function, mood, or cardiovascular risk.
Using linear and multivariable logistic regression controlling for relevant social, demographic, lifestyle, and comorbidity characteristics, we assessed the association between daily step counts and TT. This article provides general information only and is not medical advice, diagnosis, or treatment. Over-the-counter options may be inexpensive and easy to try, but their effects are often small and inconsistent. Is the aim to correct a diagnosed deficiency, improve energy and strength, or treat symptoms linked to a medical condition?